Literature DB >> 20644171

Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Jonathan D Katz1, Jennifer K Ondr, Robert J Opoka, Zacharias Garcia, Edith M Janssen.   

Abstract

In type 1 diabetes, the breach of central and peripheral tolerance results in autoreactive T cells that destroy insulin-producing, pancreatic beta cells. In this study, we identify a critical subpopulation of dendritic cells responsible for mediating both the cross-presentation of islet Ags to CD8(+) T cells and the direct presentation of beta cell Ags to CD4(+) T cells. These cells, termed merocytic dendritic cells (mcDCs), are more numerous in the NOD mouse and, when Ag-loaded, rescue CD8(+) T cells from peripheral anergy and deletion while stimulating islet-reactive CD4(+) T cells. When purified from the pancreatic lymph nodes of overtly diabetic NOD mice, mcDCs break peripheral T cell tolerance to beta cells in vivo and induce rapid onset type 1 diabetes in the young NOD mouse. Thus, the mcDC subset appears to represent the long-sought APC responsible for breaking peripheral tolerance to beta cell Ags in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644171      PMCID: PMC2916973          DOI: 10.4049/jimmunol.1001398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo.

Authors:  Simon J Prasad; Christopher C Goodnow
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

Review 2.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

Authors:  A B Lyons
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

3.  Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection.

Authors:  Benjamin D Ehst; Elizabeth Ingulli; Marc K Jenkins
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

Review 4.  Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells.

Authors:  Anja Roos; Wei Xu; Giuseppe Castellano; Alma J Nauta; Peter Garred; Mohamed R Daha; Cees van Kooten
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

5.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

6.  Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice.

Authors:  Raymond J Steptoe; Janine M Ritchie; Leonard C Harrison
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

7.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.

Authors:  Natalia Martin-Orozco; Yeonseok Chung; Seon Hee Chang; Yi-Hong Wang; Chen Dong
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

9.  The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.

Authors:  Gabrielle T Belz; Georg M N Behrens; Chris M Smith; Jacques F A P Miller; Claerwen Jones; Kristina Lejon; C Garrison Fathman; Scott N Mueller; Ken Shortman; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

10.  Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model.

Authors:  Shannon Turley; Laurent Poirot; Masakazu Hattori; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  27 in total

1.  Functional specialization of islet dendritic cell subsets.

Authors:  Na Yin; Jiangnan Xu; Florent Ginhoux; Gwendalyn J Randolph; Miriam Merad; Yaozhong Ding; Jonathan S Bromberg
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

2.  Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103- and XCR1+CD103+ dendritic cells.

Authors:  Ben Wylie; Elke Seppanen; Kun Xiao; Rachael Zemek; Damien Zanker; Sandro Prato; Bree Foley; Prue H Hart; Richard A Kroczek; Weisan Chen; Jason Waithman
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

Review 3.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

4.  Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.

Authors:  Ł Krych; D S Nielsen; A K Hansen; C H F Hansen
Journal:  Gut Microbes       Date:  2015-02-03

Review 5.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

Review 6.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

7.  Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice.

Authors:  V Dugas; A Liston; E E Hillhouse; R Collin; G Chabot-Roy; A-N Pelletier; C Beauchamp; K Hardy; S Lesage
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

8.  Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Authors:  C M Hennies; R A Reboulet; Z Garcia; S Nierkens; M C Wolkers; E M Janssen
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 9.  Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Authors:  Jonathan D Katz; Edith M Janssen
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

Review 10.  Masks in imaging flow cytometry.

Authors:  Venina Dominical; Leigh Samsel; J Philip McCoy
Journal:  Methods       Date:  2016-07-25       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.